• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis. Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity

tetano

Editor, Senior Moderator
Emerg Infect Dis. 2020 May 8;26(8). doi: 10.3201/eid2608.201160. [Epub ahead of print]
Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity.


Huang G, Kovalic AJ, Graber CJ.

Abstract

To evaluate lymphopenia as a marker for coronavirus disease severity, we conducted a meta-analysis of 10 studies. Severe illness was associated with lower lymphocyte and higher leukocyte counts. Using these markers for early identification of patients with severe disease may help healthcare providers prioritize the need to obtain therapy.



KEYWORDS:

2019 novel coronavirus disease; COVID-19; SARS-CoV-2; coronavirus disease; leukocytosis; lymphopenia; meta-analysis; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses


PMID:32384045DOI:10.3201/eid2608.201160
Free full text
 
Back
Top